- Original article
- Open access
- Published:
Study of graft survival rates of renal transplants in Cairo University Hospitals
The Egyptian Journal of Internal Medicine volume 28, pages 162–169 (2016)
Abstract
Background
Many factors and events can complicate the outcome of renal transplantation and can eventually lead to progressive renal dysfunction and graft failure. We aimed in this study to identify the risk factors for the entire course after transplantation, and then to analyze the relative impact of these risk factors on short-term and long-term graft survival in our patients.
Patients and methods
This analytical retrospective study was conducted at the King Fahd Unit, the Faculty of Medicine, Cairo University, on 104 patients for the study of 1-year graft survival, though 43 patients were followed-up for 3 years for the study of 3-year graft survival. Serum creatinine was used to evaluate the renal function; graft dysfunction was defined as serum creatinine more than 2.5 mg/dl. Survival analysis was carried out by using the Kaplan–Meier survival curve estimation. To predict the value of graft survival after 5 years, regression analysis was used.
Results
In our study, the overall graft survival rates were 88.6 and 76.7% at 1 and 3 years, respectively. The corresponding overall patient survival rates were 89.4 and 79.1% at the first and third years after transplant. Our study showed that among the long list of predictors for graft outcome variables, factors that had a significant impact on outcome by Kaplan–Meier analysis included donor’s age, primary immunosuppression, and serum creatinine 1 month after transplant. There was a greater rate of graft dysfunction with the presence of hypertension and hepatitis C virus but these results did not reach statistically significant values.
Conclusion
Old donor’s age, primary immunosuppression, and serum creatinine 1 month after transplant are the most effective factors on graft survival in kidney transplantation. Whatever the cause, graft dysfunction should be treated early and aggressively.
References
Michael A, Stephen T, Allan J, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney transplantation as primary therapy for end-stage renal disease. Clin J Am Soc Nephrol 2008; 3:471–480.
Rebollo P, Bobes J, Gonzalez MP, Saiz P, Ortega F. Factors associated with health related quality of life in patients undergoing renal replacement therapy. Nefrologia 2000; 20:171.
Seron D, Arias M, Campistol JM, Morales JM. For the Spanish chronic allograft nephropathy study group: late renal allograft failure between 1990 and 1998 in Spain: a changing scenario. Transplantation 2003; 76:1588–1594.
Ponticelli C, Tarantino A. Immunosuppressive protocols for renal transplantation. Nephrol Dial Transplant 1997; 12(Suppl 1):45–50.
Cecka JM. The UNOS renal transplant registry. In: Cecka JM, Terasaki PI, editors. Clinical transplants 2000. 10th ed. Los Angeles, CA: UCLA Tissue Typing Laboratories; 2001. 1–18.
Alfrey EJ, Boissy AR, Lerner SM. Dual kidney transplants: long-term results. Transplantation 2003; 75:1232–1236.
Siddiqi N, McBride MA, Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long term graft failure: UNOS/OPTN database analysis. Kidney Int 2004; 65:1906–1913.
McGee J, Magnus JH, Jaffe BM. Donor-recipient gender and size mismatch affects graft success after kidney transplantation. J Am Coll Surg 2010; 210:718–725.
Gjertson DW, Cecka JM. Living unrelated donor kidney transplantation. Kidney Int 2000; 58:491–499.
Raiss Jalali GA, Fazelzadeh A, Mehdizadeh AR. Effect of hypertension on transplant kidney function: three year of follow-up. Transplant Proc 2007; 39:941–942.
Arango J, Arbelaez M, Henao J, Mejia G, Arroyave I, Carvajal J, et al. Kidney graft survival in patients with hepatitis C: a single center experience. Clin Transplant 2008; 22:16–19.
Hamdy A, El-Agroudy A, Bakr MA, Amani Mostafa, Mahmou El-baz, El-Metwaly El-Shahawy, et al. Comparison of sirolimus with low dose tacrolimus regimen versus sirolimus based calcineurin inhibitor free regimen in live donor renal transplantation. Am J Transplant 2005; 5: 2531–2538.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Saadi, M.G., El-Khashab, S.O. & Mahmoud, R.M.A. Study of graft survival rates of renal transplants in Cairo University Hospitals. Egypt J Intern Med 28, 162–169 (2016). https://doi.org/10.4103/1110-7782.203296
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/1110-7782.203296